Journal of Innovative Optical Health Sciences, Volume. 8, Issue 1, 1540003(2015)

Anti-tumor activities of a novel chlorin derivative for photodynamic therapy in vitro and in vivo

Li-Jun Zhang1... Lai-Xing Wang2, Wei-Li Zhang1, Yi-Jia Yan1 and Zhi-Long Chen1,* |Show fewer author(s)
Author Affiliations
  • 1Department of Pharmaceutical Science & Technology College of Chemistry and Biology, Donghua University Shanghai 201620, P. R. China
  • 2Changhai Hospital, Second Military Medical University Shanghai 200433, P. R. China
  • show less

    In this study, a novel photosensitizer meso-tetra (3-pyrrolidinomethyl-4-methoxyphenyl) chlorin (TPMC) was reported. It displays a characteristic long wavelength absorption peak at 656 nm and it shows a singlet oxygen quantum yield of 0.48. After light irradiation with 650 nm laser, it can kill Eca-109 and SMMC-7721 cells in vitro (25mW/cm2, 1.2 to 3.6 J/cm2) and destroy Eca-109 tumor in nude mice (50mW/cm2, 90 J/cm2). It has the perspective to be developed as a new anti-tumor drug in photodynamic therapy (PDT) photodiagnosis, and deserves further investigation.

    Tools

    Get Citation

    Copy Citation Text

    Li-Jun Zhang, Lai-Xing Wang, Wei-Li Zhang, Yi-Jia Yan, Zhi-Long Chen. Anti-tumor activities of a novel chlorin derivative for photodynamic therapy in vitro and in vivo[J]. Journal of Innovative Optical Health Sciences, 2015, 8(1): 1540003

    Download Citation

    EndNote(RIS)BibTexPlain Text
    Save article for my favorites
    Paper Information

    Received: Oct. 30, 2013

    Accepted: Jan. 5, 2014

    Published Online: Jan. 10, 2019

    The Author Email: Chen Zhi-Long (zlchen1967@yahoo.com)

    DOI: 10.1142/s1793545815400039

    Topics